Dual Immune Checkpoint Inhibition in Melanoma and PD-L1 Expression: The Jury Is Still Out

被引：2
|
作者：
Schmitt, Andreas Michael [1 ]
Larkin, James [2 ]
Patel, Sapna P. [3 ]
机构：
[1] Univ Hosp Basel, Dept Med Oncol, Basel, Switzerland
[2] Royal Marsden Hosp NHS Fdn Trust, Dept Med Oncol, London, England
[3] Univ Colorado, Dept Med, Div Med Oncol, Aurora, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 02期
关键词：
ANTIBODY;
D O I：
10.1200/JCO-24-01572
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Progress in understanding the regulatory mechanisms of immune checkpoint proteins PD-1 and PD-L1 expression
    Wu, Xuanxuan
    Zhu, Zengjun
    Zhang, Jian
    Tian, Maojin
    Zhao, Peiqing
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [32] Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
    Akinleye, Akintunde
    Rasool, Zoaib
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [33] Regulation of Pulmonary Fibrosis by Immune Checkpoint PD-L1
    Geng, Y.
    Liang, C. J.
    Habiel, D. M.
    Coelho, A.
    Xie, T.
    Vrishika, K.
    Liu, N.
    Hogaboam, C. M.
    Jiang, D.
    Noble, P. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [34] Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
    Akintunde Akinleye
    Zoaib Rasool
    Journal of Hematology & Oncology, 12
  • [35] Expression of PD-L1 and PD-1 in conjunctival melanoma
    Cao, Jinfeng
    Richards, Kate
    Jordanova, Ekaterina S.
    Arinkovic, Marina
    Hurkmans, Daan
    van Duinen, Sjoerd G.
    van der Velden, Pieter A.
    Jager, Martine J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [36] Dual targeting autoinflammation and PD-L1/L2 immune checkpoint by EGCG augments anti-tumor effects in melanoma
    Li, Y.
    Menon, D. Ravindran
    Mathew, D.
    Torres, R.
    Fujita, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S145 - S145
  • [37] PD-1/PD-L1 Immune Checkpoint Inhibition with Radiation in Bladder Cancer: In Situ and Abscopal Effects
    Rompre-Brodeur, Alexis
    Shinde-Jadhav, Surashri
    Ayoub, Mina
    Piccirillo, Ciriaco A.
    Seuntjens, Jan
    Brimo, Fadi
    Mansure, Jose Joao
    Kassouf, Wassim
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (01) : 211 - 220
  • [38] Preparation of Biphenyl-Conjugated Bromotyrosine for Inhibition of PD-1/PD-L1 Immune Checkpoint Interactions
    Kim, Eun-Hye
    Kawamoto, Masuki
    Dharmatti, Roopa
    Kobatake, Eiry
    Ito, Yoshihiro
    Miyatake, Hideyuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [39] Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
    Sabrina Heynckes
    Karam Daka
    Pamela Franco
    Annette Gaebelein
    Jan Hendrik Frenking
    Roberto Doria-Medina
    Irina Mader
    Daniel Delev
    Oliver Schnell
    Dieter Henrik Heiland
    BMC Cancer, 19
  • [40] Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
    Heynckes, Sabrina
    Daka, Karam
    Franco, Pamela
    Gaebelein, Annette
    Frenking, Jan Hendrik
    Doria-Medina, Roberto
    Mader, Irina
    Delev, Daniel
    Schnell, Oliver
    Heiland, Dieter Henrik
    BMC CANCER, 2019, 19 (1)
12345